Mechanisms of contrast enhancement in magnetic resonance imaging.
The use of contrast agents has increased the sensitivity and specificity of magnetic resonance imaging (MRI). Contrast in MRI is multifactorial, depending not only on T1 and T2 relaxation rates, but also on flow, proton density and, in gradient-echo sequences, on the angle of the induced field. The use of contrast agents in MRI changes the T1 and T2 relaxation rates, producing increased signal intensity on T1-weighted images or decreased signal intensity on T2-weighted images, or both. All contrast agents produce changes in magnetic susceptibility by enhancing local magnetic fields. These effects are caused by interactions between nuclear and paramagnetic substance magnet moments, which produce accentuated transitions between spin states and cause shortening of T1; the paramagnetic substance causes accentuated local fields, which lead to increased dephasing and thus shortening of T2 or T2* relaxation time. The efficacy of shortening of T1, T2 or T2* relaxation time depends on the distance between the proton nucleus and the electronic field of the paramagnetic compound, the time of their interaction (correlation time) and the paramagnetic concentration. The MRI contrast agents currently in use cause shortening of T1, T2 or T2* relaxation time. Metal chelates (e.g., gadolinium-diethylene triamine penta-acetic acid [Gd-DTPA]) in low concentration cause shortening of T1 relaxation times, and the superparamagnetics (e.g., ferrite) cause shortening of T2 relaxation times.
Lee
D H
DH
Department of Diagnostic Radiology, University Hospital, University of Western Ontario, London.
D003287:Contrast Media / Q000494:pharmacology; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*
D003287:Contrast Media